Feature Channels: Pharmaceuticals

Filters close
Released: 13-Dec-2022 1:05 AM EST
بحاث مايو كلينك تظهر أن ببتيلوفيماب خيار موثوق لعلاج كوفيد-19 في مرحلة السلالة BA.2، أحد المتحورات الفرعية الأخرى
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا - يقول باحثو مايو كلينك إن الجسم المضاد أحادي النسيلة ببتيلوفيماب، المُرخص بالفعل من قبل إدارة الغذاء والدواء الأمريكية للاستخدام في حالات الطوارئ الخاصة بمتحور أوميكرون من فيروس كورونا المستجد (كوفيد-19)، هو خيار موثوق لعلاج سلالة BA.2 والمتحورات الفرعية الأخرى لفيروس كورونا المستجد (كوفيد-19). ونتائج دراستهم الاسترجاعية متعددة المواقع والتي شملت 3,607 مريضًا معرضين لمخاطر عالية، منشورة في مجلة الأمراض المعدية.

Comment
6-Dec-2022 2:00 PM EST
Nirmatrelvir plus ritonavir may reduce risk for hospitalization or death from COVID-19
 American College of Physicians (ACP)

A retrospective cohort study of more than 44,000 nonhospitalized persons diagnosed with COVID-19 found that nirmatrelvir plus ritonavir reduced the overall risk of hospitalization and death. The study is published in Annals of Internal Medicine.

Comment
Released: 12-Dec-2022 11:50 AM EST
In a world first: A new technology will allow efficient encapsulation and UV light-regulated release of biomolecules and drugs
 Tel Aviv University

Researchers from Tel Aviv University developed a new technology that will allow controlled encapsulation and release of molecules by exposure to UV light.

Comment
11-Dec-2022 7:00 AM EST
Novel Drug Shows Early Promise in Treating Multiple Myeloma
 Perelman School of Medicine at the University of Pennsylvania

A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania’s Abramson Cancer Center at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 565).

Comment
Newswise: Recycled gold from SIM cards could help make drugs more sustainable
Released: 9-Dec-2022 7:45 PM EST
Recycled gold from SIM cards could help make drugs more sustainable
 Imperial College London

Researchers have used gold extracted from electronic waste as catalysts for reactions that could be applied to making medicines.

Comment
8-Dec-2022 11:30 AM EST
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results
 Mount Sinai Health System

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped

Comment
Newswise:Video Embedded expanding-the-arsenal-of-drugs-against-covid-19
VIDEO
Released: 9-Dec-2022 4:40 PM EST
Expanding the arsenal of drugs against COVID-19
 Tokyo Medical and Dental University

The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, has been devastating the entire world.

Comment
Released: 9-Dec-2022 3:10 PM EST
LJI researchers find missing piece of the asthma puzzle
La Jolla Institute for Immunology

"This is a very striking and significant result that essentially separates LIGHT from any of the other inflammatory cytokines that have been implicated in the process in severe asthmatics."

Comment
   
Newswise: Johns Hopkins Researchers Explore the Concept of Belief Changes Related to Psychedelic Experiences
Released: 9-Dec-2022 9:00 AM EST
Johns Hopkins Researchers Explore the Concept of Belief Changes Related to Psychedelic Experiences
Johns Hopkins Medicine

Johns Hopkins Medicine researchers continue their exploration into psychedelics and how these drugs may produce a wide range of profound changes in perception, cognition and mood.

Comment
Released: 8-Dec-2022 11:05 PM EST
New Safety Assessment Assays Explored in Latest Issue of Toxicological Sciences
 Society of Toxicology

The December 2022 issue features 10 articles on the latest research in toxicology.

Comment
Released: 8-Dec-2022 1:35 PM EST
Researchers gain a better understanding of how the most commonly used ADHD medication works
 Elsevier

For decades, doctors have treated kids with attention-deficit/hyperactivity disorder (ADHD) with methylphenidate, a stimulant drug sold as Ritalin and Concerta, making it one of the most widely prescribed medications aimed at the central nervous system.

Comment
Released: 8-Dec-2022 1:00 PM EST
Archive Shows How Fentanyl Promotion Helped Drive Opioid Epidemic
 Johns Hopkins Bloomberg School of Public Health

The University of California, San Francisco, and Johns Hopkins University today expanded the UCSF-JHU Opioid Industry Documents Archive, adding one million pages of records from Insys Therapeutics—which manufactured and marketed the fentanyl spray Subsys.

Comment
   
Released: 8-Dec-2022 5:05 AM EST
Promising small moleculars – dispiroalkanes exhibited high effectiveness against human cytomegalovirus
 Scientific Project Lomonosov

Many pathogenic viruses, including herpesviruses, SARS -Cov-2, cytomegalovirus, papillomavirus, virus Nipah and others, use the similar mechanism to join the target cells, which consists in their attachment to heparan sulfate proteoglycan of the cell membrane.

Comment
Newswise: Novel bovine serum albumin-magnetite nanotorpedo system constructed for drug delivery
Released: 7-Dec-2022 9:05 PM EST
Novel bovine serum albumin-magnetite nanotorpedo system constructed for drug delivery
 Hefei Institutes of Physical Science, Chinese Academy of Sciences

According to a paper published in Chemical Engineering Journal recently, a team from the High Magnetic Field Laboratory (HMFL), Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences, successfully designed a safe and efficient nanotorpedo for the delivery of chemotherapeutic drugs.

Comment
   
1-Dec-2022 4:05 PM EST
Cholesterol-lowering Drugs Linked to Lower Risk of Bleeding Stroke
 American Academy of Neurology (AAN)

People who take cholesterol-lowering drugs called statins may have a lower risk of having a type of stroke called an intracerebral hemorrhage, according to a new study published in the December 7, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. An intracerebral hemorrhage is caused by bleeding in the brain.

Comment
7-Dec-2022 8:05 AM EST
New Receptor “Decoy” Drug Neutralizes COVID-19 Virus and Its Variants
 Dana-Farber Cancer Institute

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug is designed in such a way that natural selection to maintain infectiousness of the virus should also maintain the drug’s activity against future variants.

Comment
Released: 7-Dec-2022 11:45 AM EST
Let the patient choose their type 2 diabetes medication says research study
 University of Exeter

A largescale new study offers a new approach to treating in type 2 diabetes - that puts patients in charge of their own medication.

Comment
Released: 7-Dec-2022 11:40 AM EST
Are the youngest children in class overmedicated?
 Norwegian University of Science and Technology (NTNU)

Christine Strand Bachmann has led a study that includes all Norwegian children born between 1989 and 1998, a total of 488 000 people.

Comment
Newswise: Media Advisory: Cedars-Sinai Experts Available During San Antonio Breast Cancer Symposium
Released: 7-Dec-2022 11:25 AM EST
Media Advisory: Cedars-Sinai Experts Available During San Antonio Breast Cancer Symposium
 Cedars-Sinai

Physician-scientists from Cedars-Sinai Cancer are available for comment on research being presented throughout the San Antonio Breast Cancer Symposium, taking place Dec. 6-10.

Newswise: Notre Dame researchers develop new ’raspberry-shaped’ nanoparticle for precision drug delivery
Released: 7-Dec-2022 10:05 AM EST
Notre Dame researchers develop new ’raspberry-shaped’ nanoparticle for precision drug delivery
 University of Notre Dame

A newly discovered technique, reported in the journal Nanoscale, offers a low-cost way to enhance the effectiveness of existing drugs.

Comment
   


close
3.33814